2023
DOI: 10.1007/5584_2023_792
|View full text |Cite
|
Sign up to set email alerts
|

Application of the Human Amniotic Membrane as an Adjuvant Therapy for the Treatment of Hepatocellular Carcinoma

Ahmed M. Abou-Shanab,
Ola A. Gaser,
Radwa Ayman Salah
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 171 publications
0
1
0
Order By: Relevance
“…5, hsa-miR-181-a, and -b are activated by MYCN, which induces NB tumorigenesis 35 . Furthermore, it suppresses NB invasion by directly targeting non-canonical TGF-beta pathway genes 36,37 . MYCN regulates various cellular and molecular processes that support NB tumorigenicity and biomass and its expression is the highest in immature cells, which decreases the differentiation capacity of these cells.…”
Section: Discussionmentioning
confidence: 99%
“…5, hsa-miR-181-a, and -b are activated by MYCN, which induces NB tumorigenesis 35 . Furthermore, it suppresses NB invasion by directly targeting non-canonical TGF-beta pathway genes 36,37 . MYCN regulates various cellular and molecular processes that support NB tumorigenicity and biomass and its expression is the highest in immature cells, which decreases the differentiation capacity of these cells.…”
Section: Discussionmentioning
confidence: 99%